- Report
- July 2025
- 267 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 182 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 288 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 377 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 466 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 287 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 377 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 383 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 419 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 483 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 279 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 487 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 386 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 211 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 414 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 285 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 382 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 104 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 367 Pages
Global
From €5213EUR$5,850USD£4,522GBP
- Report
- July 2025
- 275 Pages
Global
From €5213EUR$5,850USD£4,522GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more